Here is the latest shareholding Pattern of REKVINA LABS. For more details, see the REKVINA LABS financial fact sheet and REKVINA LABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
3
Jun-24 |
3
Sep-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 41.30 | 41.30 | 41.30 | 41.30 | 41.30 | 45.09 | 41.30 | 41.30 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 41.30 | 41.30 | 41.30 | 41.30 | 41.30 | 45.09 | 41.30 | 41.30 | |
Mutual Funds | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Bodies Corporate | % | 4.83 | 4.83 | 4.83 | 4.83 | 4.83 | 5.26 | 4.82 | 4.82 | |
Individuals | % | 51.98 | 51.98 | 51.98 | 51.98 | 51.98 | 47.72 | 51.97 | 51.96 | |
NRIs/OCBs | % | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.00 | 0.06 | 0.06 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 1.84 | 1.84 | 1.84 | 1.84 | 1.84 | 1.93 | 1.85 | 1.86 | |
Total Non-Institution | % | 58.70 | 58.70 | 58.70 | 58.70 | 58.70 | 54.91 | 58.70 | 58.70 | |
Total Public | % | 59.00 | 59.00 | 59.00 | 59.00 | 59.00 | 55.00 | 59.00 | 59.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Trading Company Shareholding Pattern: CIPLA ZYDUS LIFESCIENCES DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.